Fortitude Family Office’s Kura Oncology KURA Stock Holding History

Fortitude Family Office’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35K	Buy	+123	New	+$1.16K	﹤0.01%	1635

Other funds holding KURA

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

XWM

Xcel Wealth Management Holly Hill, Florida $419M AUM 30.44% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Fortitude Family Office's KURA Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Kura Oncology (KURA) in Q2 2026: 123 shares worth $1.35K. The stake represents ﹤0.01% of the portfolio and ranks #1635 among its holdings.

32 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

Fortitude Family Office held 123 shares of Kura Oncology worth $1.35K as of Q2 2026.
Kura Oncology was a new Fortitude Family Office position in Q2 2026.
Kura Oncology made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1635 holding.
32 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.